Navigation Links
DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
Date:6/11/2008

EL SEGUNDO, Calif., June 11 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), recently announced that Debbie Benner, MA, RD, CSR, National Director of Nutrition Services for DaVita(R) and Mary Burgess, RD, Grant Program Manager for DaVita Clinical Research(R) have been invited to present five abstracts at the XIV International Congress on Nutrition and Metabolism in Renal Disease in Marseilles, France on June 11-15, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Benner and Burgess will join attendees from more than 40 countries to participate in this year's congress, hosted by the International Society of Nutrition and Metabolism, whose mission is to advance the knowledge of nutrition and metabolism in renal disease and renal failure and to foster communication of the advancement of this knowledge by means of scientific meetings and cooperation with scientific societies covering nephrology, nutrition, biochemistry and physiology.

The DaVita abstracts, co-authored by Benner, Burgess, David Van Wyck, MD, Kamyar Kalantar, MD and Chhaya Patel, RD, CSR, focus on the topic of albumin and mineral bone disorder management. Benner will present the oral abstracts during the educational sessions and Burgess will present the poster abstracts during scientific symposia. The Journal of Renal Nutrition will also publish the abstracts in its May issue.

"Those who care for dialysis patients struggle particularly with nutrition and mineral bone disease," said Dr. Van Wyck. "The results that will be presented in Marseilles are important not just because DaVita's clinical outcomes are impressive. They will show how to measure, organize and achieve great outcomes throughout the entire kidney care community."

DaVita and DaVita Clinical Research are trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. For more information about DaVita and its kidney education programs, please visit http://www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Receives Civil Complaint
2. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
3. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
4. DaVita Volunteers Raise More than $1,000,000 for Nationwide Kidney Education and Prevention Programs
5. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
6. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
7. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. DaVita Announces Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology: